IL89654A0 - Pharmaceutical combination preparations for treating hypertension - Google Patents

Pharmaceutical combination preparations for treating hypertension

Info

Publication number
IL89654A0
IL89654A0 IL89654A IL8965489A IL89654A0 IL 89654 A0 IL89654 A0 IL 89654A0 IL 89654 A IL89654 A IL 89654A IL 8965489 A IL8965489 A IL 8965489A IL 89654 A0 IL89654 A0 IL 89654A0
Authority
IL
Israel
Prior art keywords
pharmaceutical combination
combination preparations
treating hypertension
formula
image
Prior art date
Application number
IL89654A
Other versions
IL89654A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL89654A0 publication Critical patent/IL89654A0/en
Publication of IL89654A publication Critical patent/IL89654A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)

Abstract

Pharmaceutical combination preparations containing a beta -blocker of the formula <IMAGE> and a pyridazodiazepine of the formula <IMAGE> in which R, R<1>, R<2>, R<3>, R<4> and R<5> have the meaning stated in claim 1, have a pronounced lowering effect on blood pressure without increasing the heart rate and are accordingly suitable for controlling or preventing hypertension and its sequelae.
IL89654A 1988-03-24 1989-03-17 Pharmaceutical combination compositions for treating hypertension IL89654A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH111488 1988-03-24

Publications (2)

Publication Number Publication Date
IL89654A0 true IL89654A0 (en) 1989-09-28
IL89654A IL89654A (en) 1993-06-10

Family

ID=4202814

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89654A IL89654A (en) 1988-03-24 1989-03-17 Pharmaceutical combination compositions for treating hypertension

Country Status (13)

Country Link
EP (1) EP0334164B1 (en)
JP (1) JPH01283224A (en)
KR (1) KR890014116A (en)
AT (1) ATE96322T1 (en)
AU (1) AU616249B2 (en)
CS (1) CS395291A3 (en)
DE (1) DE58905990D1 (en)
DK (1) DK140389A (en)
HU (1) HU206612B (en)
IL (1) IL89654A (en)
MC (1) MC2019A1 (en)
MX (1) MX9203171A (en)
ZA (1) ZA892061B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409631D1 (en) * 1993-07-15 2001-02-15 Hoffmann La Roche Pharmaceutical combination containing an inhibitor of the renin-angiotensin system and an endothelin antagonist
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW11586A1 (en) * 1985-07-01 1987-12-30 Hoffmann La Roche Bicyclic compounds
DE3542794A1 (en) * 1985-12-04 1987-06-11 Bayer Ag ANTI-HYPERTENSIVE COMBINATION PREPARATION

Also Published As

Publication number Publication date
DK140389A (en) 1989-09-25
KR890014116A (en) 1989-10-21
EP0334164B1 (en) 1993-10-27
EP0334164A3 (en) 1990-05-23
DK140389D0 (en) 1989-03-21
HU206612B (en) 1992-12-28
EP0334164A2 (en) 1989-09-27
ZA892061B (en) 1989-11-29
DE58905990D1 (en) 1993-12-02
MC2019A1 (en) 1990-02-23
CS395291A3 (en) 1992-06-17
ATE96322T1 (en) 1993-11-15
AU616249B2 (en) 1991-10-24
MX9203171A (en) 1992-07-01
IL89654A (en) 1993-06-10
HUT50281A (en) 1990-01-29
JPH01283224A (en) 1989-11-14
AU3145689A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
HU9303458D0 (en) Process for producing sulfonamides and pharmaceutical preparations containing them
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
AU1033292A (en) Indole piperazine derivatives and pharmaceutical preparations containing such derivatives
CZ285522B6 (en) Medicament for reducing concentration of glucose in blood
EP0326307A3 (en) Novel pyridazinone derivatives and pharmaceutical preparations containing them
GB9206244D0 (en) Cytotoxic compound from a marine sponge
HU9201288D0 (en) Kinoxalyne derivatives, process for their production and medical preparations containing them
AU8261787A (en) Medicaments for the treatment of depression
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
NO893826D0 (en) PROCEDURE FOR THE PREPARATION OF 2&#39;-HALOMETHYLIDE, 2&#39;-ETHENYLIDE AND 2&#39;-ETHENYLADENOSIN DERIVATIVES.
AU4175893A (en) Treatment of inflammatory bowel disease
IL89654A0 (en) Pharmaceutical combination preparations for treating hypertension
AU1643592A (en) Novel compound and use of the same as medicine
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
NO883986L (en) PROCEDURE FOR THE PREPARATION OF N- (SUBSTITUTED ALKYLIDE) -1,2,3,4-TETRAHYDRO-9 ACRIDINAMINES AND USE THEREOF AS MEDICINES.
DK284588A (en) BETA-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS.
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
ZA924128B (en) New combination preparations for treatment of Parkinson&#39;s disease.
AU613510B2 (en) Use of zofenopril for the treatment of rheumatoid arthritis
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
ZA874878B (en) Pyran derivatives
IL105599A0 (en) Enantiomers derived from(s)-2-amino-2(3,4-dichlorobenzyl)-1-propanol and pharmaceutical compositions containing same
IT9048106A0 (en) MEDICINAL ASSOCIATION FOR THE TREATMENT OF HYPERTENSION AND CONGESTIVE HEART FAILURE. (CASE 100-7516)
ZA925928B (en) N-azinyl-N&#39;-(2-ethylsulphinyl-phenylsulphonyl)-ureas.